MRK
Merck & Co., Inc. · Healthcare
Chair, CEO and President Robert M Davis sold $16.5M of Merck & Co., Inc.
Sold$16,472,845
$114.93Price
143,329Shares
−35%Stake
What MRK did after the filing
- The stock from Mon, May 1 open, $115.80
- −5.0%
- S&P 500, same days
- +5.1%
Measured over 30 trading days, to the Jun 13 close.
Traded Fri, Apr 28. Filed Fri, Apr 28, 5:15 PM ET, after the close. Returns use the May 1 open and the Jun 13 close. Not investment advice.